Your browser doesn't support javascript.
loading
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
Overton, Edgar Turner; Lawrence, Steven J; Wagner, Eva; Nopora, Katrin; Rösch, Siegfried; Young, Philip; Schmidt, Darja; Kreusel, Christian; De Carli, Sonja; Meyer, Thomas P; Weidenthaler, Heinz; Samy, Nathaly; Chaplin, Paul.
Afiliação
  • Overton ET; Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States of America.
  • Lawrence SJ; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Wagner E; Bavarian Nordic GmbH, Martinsried, Germany.
  • Nopora K; Bavarian Nordic GmbH, Martinsried, Germany.
  • Rösch S; Bavarian Nordic GmbH, Martinsried, Germany.
  • Young P; Bavarian Nordic GmbH, Martinsried, Germany.
  • Schmidt D; Bavarian Nordic GmbH, Martinsried, Germany.
  • Kreusel C; Bavarian Nordic GmbH, Martinsried, Germany.
  • De Carli S; Bavarian Nordic GmbH, Martinsried, Germany.
  • Meyer TP; Bavarian Nordic GmbH, Martinsried, Germany.
  • Weidenthaler H; Bavarian Nordic GmbH, Martinsried, Germany.
  • Samy N; Bavarian Nordic GmbH, Martinsried, Germany.
  • Chaplin P; Bavarian Nordic GmbH, Martinsried, Germany.
PLoS One ; 13(4): e0195897, 2018.
Article em En | MEDLINE | ID: mdl-29652929

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article